Valter. Agosti, et.al., A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis., Experimental hematology, 2009, 37

http://rdf.ncbi.nlm.nih.gov/pubmed/19100679

Valter. Agosti, et.al., A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis., Experimental hematology, 2009, 37

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased erythroblast number_Kit<tm3.1Bsm>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0011178B6129S1Kittm31BsmKittm31BsmKittm31BsmKittm31Bsm
• increased sensitivity to xenobiotic induced morbidity/mortality_Kit<tm3.1Bsm>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0009766B6129S1Kittm31BsmKittm31BsmKittm31BsmKittm31Bsm
• increased erythroid progenitor cell number_Lyn<tm1Sor>/Lyn<tm1Sor>
  http://metadb.riken.jp/0003135I129S4SvJaeSorLyntm1SorLyntm1SorLyntm1Sor
• decreased hematocrit_Kit<tm3.1Bsm>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0000208B6129S1Kittm31BsmKittm31BsmKittm31BsmKittm31Bsm
• spleen hypoplasia_Kit<tm3.1Bsm>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0000694B6129S1Kittm31BsmKittm31BsmKittm31BsmKittm31Bsm
• abnormal erythroid progenitor cell morphology_Kit<tm2Ber>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0008801I129S1Sv129X1SvJC57BL6JKittm2BerKittm31BsmKittm2BerKittm31Bsm
• abnormal proerythroblast morphology_Kit<tm3.1Bsm>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0002416B6129S1Kittm31BsmKittm31BsmKittm31BsmKittm31Bsm
• abnormal erythropoiesis_Kit<tm3.1Bsm>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0000245B6129S1Kittm31BsmKittm31BsmKittm31BsmKittm31Bsm
• abnormal proerythroblast morphology_Kit<tm2Ber>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0002416I129S1Sv129X1SvJC57BL6JKittm2BerKittm31BsmKittm2BerKittm31Bsm
• abnormal proerythroblast morphology_Lyn<tm1Sor>/Lyn<tm1Sor>
  http://metadb.riken.jp/0002416I129S4SvJaeSorLyntm1SorLyntm1SorLyntm1Sor
• abnormal response/metabolism to endogenous compounds_Kit<tm3.1Bsm>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0003638B6129S1Kittm31BsmKittm31BsmKittm31BsmKittm31Bsm
• increased mean corpuscular volume_Kit<tm3.1Bsm>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0002590B6129S1Kittm31BsmKittm31BsmKittm31BsmKittm31Bsm
• decreased erythrocyte cell number_Kit<tm3.1Bsm>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0002875B6129S1Kittm31BsmKittm31BsmKittm31BsmKittm31Bsm
• increased physiological sensitivity to xenobiotic_Kit<tm3.1Bsm>/Kit<tm3.1Bsm>
  http://metadb.riken.jp/0008873B6129S1Kittm31BsmKittm31BsmKittm31BsmKittm31Bsm